{"transactions":[{"id":781931,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-12T20:30:19.000Z","date":"2026-05-09","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on June 9, 2026; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":22000,"derivative":{"exercise_price":1.58,"expiration_date":"2036-05-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001839156-26-000002","document":"form4-05122026_040508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000183915626000002/form4-05122026_040508.xml","form_type":"4"}},{"id":1151913,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-12T20:15:17.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":63150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on June 8, 2025; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":63150,"derivative":{"exercise_price":0.17,"expiration_date":"2035-05-08","underlying":"Common Stock","underlying_shares":63150},"source":{"system":"sec-edgar","filing":"0001415889-25-012651","document":"form4-05122025_040512.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925012651/form4-05122025_040512.xml","form_type":"4"}},{"id":1155871,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:15.000Z","date":"2025-04-27","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":81967,"derivative":{"exercise_price":0.45,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-25-012291","document":"form4-05072025_080511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925012291/form4-05072025_080511.xml","form_type":"4"}},{"id":1155870,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrants (right to buy)","published_at":"2025-05-08T00:45:15.000Z","date":"2025-04-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the \"old\" warrant and the grant of a \"replacement\" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.5,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001415889-25-012291","document":"form4-05072025_080511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588925012291/form4-05072025_080511.xml","form_type":"4"}},{"id":1322540,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-23T21:15:25.000Z","date":"2024-12-19","kind":"grant","planned":false,"acquired":true,"shares":37655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date."}],"balance_after":37655,"derivative":{"exercise_price":0.24,"expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":37655},"source":{"system":"sec-edgar","filing":"0001415889-24-030066","document":"form4-12232024_041222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924030066/form4-12232024_041222.xml","form_type":"4"}},{"id":1478407,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T21:00:11.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":33650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 12, 2024; provided, however, that the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders, subject to\nthe Reporting Person continuing to provide service through each such date."}],"balance_after":33650,"derivative":{"exercise_price":1.47,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":33650},"source":{"system":"sec-edgar","filing":"0001415889-24-016966","document":"form4-06142024_050607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924016966/form4-06142024_050607.xml","form_type":"4"}},{"id":1652961,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-08T21:54:21.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36th) of the shares subject to the option shall vest in equal monthly installments commencing on March 7, 2024, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":12500,"derivative":{"exercise_price":1.22,"expiration_date":"2034-02-07","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-24-003025","document":"form4-02082024_090213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000141588924003025/form4-02082024_090213.xml","form_type":"4"}},{"id":1708668,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Warrants (right to buy)","published_at":"2023-12-15T13:26:13.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":81967,"derivative":{"exercise_price":1.5,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001209191-23-058720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123058720/doc4.xml","form_type":"4"}},{"id":1708667,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A  Warrants (right to buy)","published_at":"2023-12-15T13:26:13.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":81967,"derivative":{"exercise_price":1.25,"expiration_date":"2025-06-13","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001209191-23-058720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123058720/doc4.xml","form_type":"4"}},{"id":1708666,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T13:26:13.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":81967,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock."}],"balance_after":81967,"source":{"system":"sec-edgar","filing":"0001209191-23-058720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123058720/doc4.xml","form_type":"4"}},{"id":1717393,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-08T21:26:08.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":54800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36th) of the shares subject to the option shall vest in equal monthly installments commencing on January 6, 2024, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":54800,"derivative":{"exercise_price":1.04,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":54800},"source":{"system":"sec-edgar","filing":"0001209191-23-057915","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740279/000120919123057915/doc4.xml","form_type":"4"}},{"id":2050670,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T17:15:21.000Z","date":"2023-01-19","kind":"disposition_to_issuer","acquired":false,"shares":22500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":4.27,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000899243-23-002190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000089924323002190/doc4.xml","form_type":"4"}},{"id":2050669,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T17:15:21.000Z","date":"2023-01-19","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":6.46,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-23-002190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000089924323002190/doc4.xml","form_type":"4"}},{"id":2050668,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T17:15:21.000Z","date":"2023-01-19","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was fully vested and exercisable prior to the Effective Time. Pursuant to the terms of the Merger Agreement, each option to purchase shares of the Company's common stock was canceled and converted into the right to receive an amount in cash, if any, equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price of such stock option and (ii) the number of shares of common stock underlying such option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":6.31,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-23-002190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000089924323002190/doc4.xml","form_type":"4"}},{"id":2238970,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-08T16:58:33.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in twelve equal monthly installments beginning July 1, 2022, subject to the Reporting Person's continued service to the Company."}],"balance_after":22500,"derivative":{"exercise_price":4.27,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001628280-22-016603","document":"wf-form4_165472189665790.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000162828022016603/wf-form4_165472189665790.xml","form_type":"4"}},{"id":2749439,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-14T18:21:55.000Z","date":"2021-04-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal monthly installments from February 1, 2021 through January 1, 2024, subject to the Reporting Person's continued service to the Company."}],"balance_after":15000,"derivative":{"exercise_price":6.46,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-21-015831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000089924321015831/doc4.xml","form_type":"4"}},{"id":2912095,"issuer":{"id":120602,"kind":"organization","name":"AVEO PHARMACEUTICALS, INC.","symbol":"AVEO"},"owners":[{"id":47897,"kind":"person","name":"Epperly Corinne","position":1,"cik":"0001839156","reported_name":"Epperly Corinne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-08T19:01:53.000Z","date":"2021-01-06","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal monthly installments from February 1, 2021 through January 1, 2024, subject to the Reporting Person's continued service to the Company."}],"balance_after":10000,"derivative":{"exercise_price":6.31,"expiration_date":"2031-01-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-001226","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1325879/000089924321001226/doc4.xml","form_type":"4"}}]}